Filing Details
- Accession Number:
- 0000950170-24-106610
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-16 08:00:27
- Reporting Period:
- 2024-09-12
- Accepted Time:
- 2024-09-16 08:00:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178253 | Scynexis Inc | SCYX | Pharmaceutical Preparations (2834) | 562181648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1644071 | David Gonzalez Angulo | 1 Evertrust Plaza 13Th Floor Jersey City NJ 07302 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-12 | 20,000 | $1.37 | 507,871 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- Includes 8,000 shares of common stock acquired under the 2014 Employee Stock Purchase Plan on March 5, 2024 (4,000 shares) and September 5, 2024 (4,000 shares).
Billionaire Hedge Funds
